Akums Drugs and Pharmaceuticals Limited — Others, 07-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Akums Drugs and Pharmaceuticals has announced a board meeting on April 15, 2025, to discuss the financial results for the quarter and half-year ending March 31, 2025. The company received a compliance certificate from MUFG Intime India Private Limited, confirming adherence to SEBI regulations regarding the dematerialization of securities for the quarter. This reflects the company's commitment to maintaining good governance and operational standards. The announcement could contribute to a positive outlook among investors, reinforcing confidence in the company's transparency and operational processes.